You are here

Bayer

Bayer cues up filings for rival to Astellas’ menopause drug

Pharmaphorum

Tue, 03/19/24 - 11:35 am

Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial

Fierce Biotech

Tue, 03/19/24 - 11:21 am

neovascular age-related macular degeneration

Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets

BioSpace

Sun, 03/17/24 - 09:19 pm

artificial intelligence

drug development

Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO

BioPharma Dive

Thu, 03/7/24 - 11:13 am

Arch Venture Partners

Bayer CEO launches ‘full-scale effort’ to rejuvenate pharma pipeline, tables split-up but warns not never

Fierce Pharma

Tue, 03/5/24 - 11:37 am

Bayer pays $310M to buy into BridgeBio heart drug

BioPharma Dive

Mon, 03/4/24 - 11:52 am

transthyretin amyloidosis cardiomyopathy

Bayer wins FDA breakthrough therapy designation for NSCLC candidate

Clinical Trials Arena

Mon, 02/26/24 - 05:16 pm

breakthrough designation

non-small cell lung cancer

Another tough decision for Bayer as it plans to slash dividend by 95% to reduce debt

Fierce Pharma

Tue, 02/20/24 - 05:46 pm

Bayer makes a deal on popular contraceptive with Mark Cuban's online pharmacy

NPR

Tue, 02/20/24 - 11:03 am

Cost Plus Drugs

Bayer, Moderna-Backed Metagenomi’s Stock Crashes 31% in Friday IPO Debut

BioSpace

Mon, 02/12/24 - 11:51 am

Bayer shares fall nearly 6% on court order to pay $2.25 bln in damages

Reuters

Mon, 01/29/24 - 10:56 am

Bayer CEO Bill Anderson makes his mark with major restructuring, 'significant' job cuts

Fierce Pharma

Thu, 01/18/24 - 11:03 am

Bayer and AskBio begin Phase II congestive heart failure treatment trial

Clinical Trials Arena

Fri, 01/12/24 - 09:54 am

congestive heart failure

clinical trials

Bayer's menopausal relief drug succeeds in late-stage trial

Reuters

Mon, 01/8/24 - 11:23 am

clinical trials

Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data

Fierce Biotech

Thu, 01/4/24 - 10:12 am

Parkinson's Disease

Bayer, Now Facing Headwinds, Has A History Of Bold Innovation

Forbes

Tue, 11/28/23 - 10:22 am

Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst

Fierce Pharma

Tue, 11/21/23 - 10:43 pm

Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast

Fierce Biotech

Mon, 11/20/23 - 11:41 am

clinical trials

J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses

Fierce Pharma

Tue, 11/14/23 - 09:56 pm

peripheral artery disease

Bayer to withdraw follicular lymphoma therapy after trial failure

Clinical Trials Arena

Tue, 11/14/23 - 09:37 am

relapsed follicular lymphoma

clinical trials

Pages